Chenxin Pharmaceuticals: Sishiyao completed the reduction of 4.52 million shares, reducing its shareholding to 5.11%.

Chenxin Pharmaceutical announced that shareholder Shijiazhuang Siyao Co., Ltd., holding more than 5% of the shares, has completed its reduction plan. Before the reduction, Shijiazhuang Siyao held 27,661,441 shares of the company's freely tradable shares, accounting for 6.11% of the total share capital. On August 30, 2025, it disclosed a plan to reduce holdings, intending to reduce up to 4,527,000 shares through centralized bidding. As of September 24, Shijiazhuang Siyao has cumulatively reduced 4,520,000 shares, accounting for 0.998% of the total share capital, at a reduction price range of 19.70 - 21.17 yuan/share, with a total reduction amount of 91,220,564 yuan. After the reduction, Shijiazhuang Siyao's holdings decreased to 23,141,441 shares, with a shareholding ratio of 5.11%. This reduction is consistent with the plan and has not been terminated early.